DE69718150D1 - Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien - Google Patents

Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien

Info

Publication number
DE69718150D1
DE69718150D1 DE69718150T DE69718150T DE69718150D1 DE 69718150 D1 DE69718150 D1 DE 69718150D1 DE 69718150 T DE69718150 T DE 69718150T DE 69718150 T DE69718150 T DE 69718150T DE 69718150 D1 DE69718150 D1 DE 69718150D1
Authority
DE
Germany
Prior art keywords
allergies
treatment
immunogenes
peptid
vaccination against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69718150T
Other languages
English (en)
Other versions
DE69718150T3 (de
DE69718150T2 (de
Inventor
Franz Kricek
Beda Stadler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26308839&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69718150(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9604412.8A external-priority patent/GB9604412D0/en
Priority claimed from GBGB9617702.7A external-priority patent/GB9617702D0/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE69718150D1 publication Critical patent/DE69718150D1/de
Application granted granted Critical
Publication of DE69718150T2 publication Critical patent/DE69718150T2/de
Publication of DE69718150T3 publication Critical patent/DE69718150T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/528—CH4 domain
DE69718150T 1996-03-01 1997-02-28 Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien Expired - Lifetime DE69718150T3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9604412 1996-03-01
GBGB9604412.8A GB9604412D0 (en) 1996-03-01 1996-03-01 Organic compounds
GBGB9617702.7A GB9617702D0 (en) 1996-08-22 1996-08-22 Organic compounds
GB9617702 1996-08-22
PCT/EP1997/001013 WO1997031948A1 (en) 1996-03-01 1997-02-28 Peptide immunogens for vaccination against and treatment of allergy

Publications (3)

Publication Number Publication Date
DE69718150D1 true DE69718150D1 (de) 2003-02-06
DE69718150T2 DE69718150T2 (de) 2003-08-21
DE69718150T3 DE69718150T3 (de) 2009-03-05

Family

ID=26308839

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69718150T Expired - Lifetime DE69718150T3 (de) 1996-03-01 1997-02-28 Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien

Country Status (25)

Country Link
US (1) US6610297B1 (de)
EP (1) EP0885244B2 (de)
JP (2) JP3421970B2 (de)
KR (2) KR100498198B1 (de)
CN (1) CN1174998C (de)
AT (1) ATE230417T1 (de)
AU (1) AU719609B2 (de)
BR (1) BR9707819A (de)
CA (1) CA2245497C (de)
CY (1) CY2457B1 (de)
CZ (1) CZ299551B6 (de)
DE (1) DE69718150T3 (de)
DK (1) DK0885244T4 (de)
ES (1) ES2190799T5 (de)
HK (1) HK1014962A1 (de)
HU (1) HUP9901109A3 (de)
IL (1) IL125590A (de)
NO (1) NO321043B1 (de)
NZ (1) NZ331651A (de)
PL (1) PL187209B1 (de)
RU (1) RU2193413C2 (de)
SI (1) SI0885244T2 (de)
SK (1) SK284856B6 (de)
TR (1) TR199801722T2 (de)
WO (1) WO1997031948A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
EP1621209A3 (de) * 1998-11-02 2006-04-19 Resistentia Pharmaceuticals AB Vakzinen die auf Domänen von chimären Immunoglobulin E Peptide basieren
IL143441A0 (en) 1998-11-30 2002-04-21 Cytos Biotechnology Ag Non-naturally occuring antigen arrays and processes for the preparation thereof
CZ20013081A3 (cs) * 1999-02-25 2002-02-13 Smithkline Beecham Biologicals S. A. Epitopy a mimotopy získané z oblastí C-epsilon-2 nebo C-epsilon-4 IgE, jejich antagonisté a jejich terapeutické pouľití
CA2363118A1 (en) * 1999-02-25 2000-08-31 Smithkline Beecham Biologicals S.A. Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
GB9908533D0 (en) * 1999-04-14 1999-06-09 Novartis Ag Organic compounds
WO2001078766A1 (de) * 2000-04-13 2001-10-25 Bio Life Science Forschungs Und Entwicklungsgesellschaft Mbh Vakzine gegen krebserkrankungen, die sich auf mimotope von auf tumorzellen exprimierte antigenen stützt
AU2001252458A1 (en) 2000-05-05 2001-11-20 Martin Bachmann Molecular antigen arrays and vaccines
US6887472B2 (en) 2000-08-30 2005-05-03 Pfizer Inc. Anti-IgE vaccines
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
ES2394293T3 (es) * 2001-02-28 2013-01-30 Bio Life Science Forschungs- Und Entwicklungsges.M.B.H. Vacuna contra cánceres que están asociados con el oncogén HER-2/neu
EP1239032A1 (de) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Milchsäurebakterien als Mitteln zur Behandlung und Vorbeugung von Allergie
JP2003047482A (ja) 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
US7604955B2 (en) 2001-08-13 2009-10-20 Swey-Shen Alex Chen Immunoglobulin E vaccines and methods of use thereof
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
ATE361097T1 (de) * 2002-01-15 2007-05-15 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh Orale vakzinierung mit dem tumor-antigen-mimotop gln-met-trp-ala-pro-gln-trp-gly-pro-asp
AU2003246690B2 (en) 2002-07-17 2010-03-11 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
EP2392345A3 (de) 2002-07-18 2012-03-07 Cytos Biotechnology AG Haptenträgerkonjugate mit virusähnlichen Partikeln und Verwendungen davon
SI1524994T1 (sl) 2002-07-19 2011-08-31 Cytos Biotechnology Ag Sestavki cepiv, ki vsebujejo amiloidne beta 1-6 antigenske mreĹľe
EP1534335B9 (de) 2002-08-14 2016-01-13 Macrogenics, Inc. Fcgammariib-spezifische antikörper und verfahren zur verwendung davon
US20050065136A1 (en) * 2003-08-13 2005-03-24 Roby Russell R. Methods and compositions for the treatment of infertility using dilute hormone solutions
WO2005105106A2 (en) * 2004-04-21 2005-11-10 Roby Russell R Hormone treatment of macular degeneration
US20060025390A1 (en) * 2004-07-28 2006-02-02 Roby Russell R Treatment of hormone allergy and related symptoms and disorders
ITMI20052517A1 (it) * 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
WO2008019199A2 (en) 2006-06-26 2008-02-14 Macrogenics, Inc. FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
EP2012122A1 (de) * 2007-07-06 2009-01-07 Medigene AG Strukturproteine von mutierten Parvoviren als Impfstoffe
US8865179B2 (en) * 2008-01-26 2014-10-21 Swey-Shen Alexchen Aptameric IgE peptides in a protein scaffold as an allergy vaccine
JP5209800B2 (ja) 2008-12-09 2013-06-12 ファイザー バクシーンズ エルエルシー ＩｇＥＣＨ３ペプチドワクチン
WO2011154878A1 (en) 2010-06-07 2011-12-15 Pfizer Vaccines Llc Ige ch3 peptide vaccine
RU2761431C9 (ru) * 2020-10-26 2022-04-18 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602443A1 (de) 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4171299A (en) 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
DE2861593D1 (en) 1977-06-29 1982-03-11 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
JPS5944399A (ja) 1982-09-07 1984-03-12 Takeda Chem Ind Ltd 新規ｄｎａ
GB8616166D0 (en) * 1986-07-02 1986-08-06 Research Corp Ltd Polypeptide competitor
US4892827A (en) 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
EP0269455A3 (de) 1986-11-28 1989-09-06 Takeda Chemical Industries, Ltd. Hochgereinigtes Fusionsprotein, das ein menschliches IgE Fc-Fragment enthält, sowie dessen Herstellung
WO1988006040A1 (en) 1987-02-20 1988-08-25 Imclone Systems, Inc. Monoclonal antibodies in vaccine formulations
CA1336818C (en) 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
KR890701761A (ko) 1987-10-13 1989-12-21 제롤드 엘.글릭 면역 진단시약의 제조방법
GB8727045D0 (en) 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
US5449760A (en) 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5342924A (en) 1987-12-31 1994-08-30 Tanox Biosystems, Inc. Extracellular segments of human ε immunoglobulin anchoring peptides and antibodies specific therefor
GB8910263D0 (en) 1989-05-04 1989-06-21 Ciba Geigy Ag Monoclonal antibodies specific for an immunoglobulin isotype
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
DE69126607T2 (de) 1990-01-23 1998-01-15 Tanox Biosystems Inc Extrazelluläre teilstücke humaner ige-immunoglobulin-ankerpeptide und dafür spezifische antikörper
JPH05508835A (ja) 1990-05-25 1993-12-09 ペプチド・セラピューティクス・リミテッド 慢性関節リウマチの免疫診断検定法
US5258289A (en) 1990-09-05 1993-11-02 Davis Claude G Method for the selecting of genes encoding catalytic antibodies
GB9101550D0 (en) 1991-01-24 1991-03-06 Mastico Robert A Antigen-presenting chimaeric protein
DK1260521T3 (da) * 1991-08-14 2008-03-25 Genentech Inc Immunoglobulinvarianter af specifikke Fc-epsilonreceptorer
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
SE9102808L (sv) 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
GB9125024D0 (en) 1991-11-25 1992-01-22 Kirby Julian Rheumatoid arthritus treatment
JPH06113881A (ja) 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするｄｎａ
US5759551A (en) 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
DE69431114T2 (de) 1993-04-27 2003-03-13 United Biomedical Inc Immunogene lhrh peptidkonstrukion und synthetische, universale immunstimulatoren als impfstoffe
JPH09500615A (ja) 1993-05-14 1997-01-21 ジェネンテク，インコーポレイテッド Ｒａｓ−ファルネシル転移酵素阻害剤
GB9320897D0 (en) 1993-10-11 1993-12-01 Peptide Therapeutics Ltd Compounds useful in anti-allergy treatment
GB9324013D0 (en) 1993-11-22 1994-01-12 3I Res Expl Ltd Polypeptides
FR2715304B1 (fr) * 1994-01-26 1996-04-26 Merieux Serums Vaccins Pasteur Vaccin anti-allergique.
EP0811016A1 (de) * 1994-03-28 1997-12-10 United Biomedical, Inc. Auf synthetischen peptiden basierende immunogene für die behandlung der allergie
WO1996001643A1 (en) 1994-07-08 1996-01-25 Thomas Jefferson University IgE ANTAGONISTS
WO1996012740A1 (en) 1994-10-25 1996-05-02 United Biomedical, Inc. SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY
AU6532498A (en) 1996-12-06 1998-06-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Inhibition of ige-mediated allergies by a human ige-derived oligopeptide
EP0955311A3 (de) 1998-04-09 2000-08-16 Idexx Laboratories, Inc. Peptidscher Impfstoff für Hundenallergie
TWI229679B (en) 1998-06-20 2005-03-21 United Biomedical Inc Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens

Also Published As

Publication number Publication date
KR100498198B1 (ko) 2005-09-09
ATE230417T1 (de) 2003-01-15
ES2190799T5 (es) 2008-08-16
EP0885244A1 (de) 1998-12-23
DE69718150T3 (de) 2009-03-05
JP2003231696A (ja) 2003-08-19
NO983999L (no) 1998-11-02
TR199801722T2 (xx) 1998-12-21
SK284856B6 (sk) 2006-01-05
HK1014962A1 (en) 1999-10-08
SI0885244T2 (sl) 2008-10-31
JP3421970B2 (ja) 2003-06-30
NO983999D0 (no) 1998-08-31
RU2193413C2 (ru) 2002-11-27
PL328858A1 (en) 1999-03-01
CA2245497A1 (en) 1997-09-04
SI0885244T1 (en) 2003-06-30
EP0885244B2 (de) 2008-04-16
CA2245497C (en) 2009-02-24
US6610297B1 (en) 2003-08-26
HUP9901109A3 (en) 1999-11-29
CN1213380A (zh) 1999-04-07
CN1174998C (zh) 2004-11-10
IL125590A0 (en) 1999-03-12
KR20050049509A (ko) 2005-05-25
SK118198A3 (en) 1999-03-12
NO321043B1 (no) 2006-03-06
NZ331651A (en) 2000-01-28
CY2457B1 (en) 2005-06-03
BR9707819A (pt) 1999-07-27
KR100584051B1 (ko) 2006-05-30
CZ299551B6 (cs) 2008-08-27
CZ277198A3 (cs) 1998-12-16
DE69718150T2 (de) 2003-08-21
ES2190799T3 (es) 2003-08-16
HUP9901109A2 (hu) 1999-07-28
AU1879697A (en) 1997-09-16
JP2000502571A (ja) 2000-03-07
DK0885244T3 (da) 2003-04-22
IL125590A (en) 2001-08-26
DK0885244T4 (da) 2008-06-16
PL187209B1 (pl) 2004-06-30
EP0885244B1 (de) 2003-01-02
AU719609B2 (en) 2000-05-11
KR19990087425A (ko) 1999-12-27
WO1997031948A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
DE69718150D1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
DE69703689T2 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
DE60221665D1 (de) Impfstoff zur verhütung und behanldung von alzheimer-demenz und von amyloid-bezogenen krankheiten
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
CY1107578T1 (el) Πεπτιδια που χρησιμευουν στη θepαπεια ογκων και αλλων καταστασεων που χρηζουν την αφαιρεση ή την καταστροφη κυτταρων
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
DE69806801T2 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
BR9913564A (pt) Tratamento de angiopatias microvasculares
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69723580D1 (de) Impfstoff gegen metastasierenden kolorektalkrebs.
ATE283920T1 (de) Verfahren zur immunisierung und behandlung von h. pylori infektion
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
DE60044539D1 (de) Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien
ATE255594T1 (de) Hepatitis b inhibitoren
ATE196424T1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
DE60037349D1 (de) Zusammensetzungen und Verfahren zur Behandlung von Tumoren
DE60030593D1 (de) Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN